Early studies with selective beta blockers, such as bisoprolol and metoprolol XL, and with nonselective beta blockers, such as carvedilol, have demonstrated survival benefit in patients with congestive heart failure. A more recent trial of bucindolol
Proximal plantar fasciitis, a common cause of heel pain, theoretically may be caused by partial tearing of the plantar fascia and inflammation at its insertion on the medial tubercle of the calcaneus. Nonsurgical treatments include shoe modifications,
In the early 1980s, expert opinion suggested that Chlamydia trachomatis coexisted with Neisseria gonorrhoeae in up to 45 percent of patients infected with the latter organism. The Centers for Disease Control and Prevention (CDC) recommended that patie
Examination of patients with eye problems often requires topical ophthalmic anesthesia. Tetracaine hydrochloride solution commonly is used because it easily penetrates all three layers of the cornea. Instillation of ophthalmic analgesics can be painfu
Hypertension and proteinuria are risk factors for faster progression of kidney disease. Pharmacologic control of hypertension reduces urine protein excretion and slows progression of the disease. Recent guidelines included in the seventh report of the
Multiple physician groups and the U.S. Preventive Services Task Force recommend that physicians counsel postmenopausal patients about the individual risks and benefits of using hormone therapy. Currently, information about the risks and benefits of ho
Worldwide, approximately 50,000 deaths per year are caused by rabies, but a firm estimate is hard to come by because reporting mechanisms in many developing countries where rabies is endemic are unreliable or nonexistent. In many parts of the world, l
Women have a lower risk of cardiovascular mortality than men, and female sex hormones have been considered to be a protective factor. Support for this advantage includes the low rate of coronary heart disease in premenopausal women, the increased occu
Insulin resistance is recognized as a major risk factor for cardiovascular disease. Fasting glucose concentration can be determined easily, but glucose response to an oral glucose challenge appears to be a more sensitive predictor of cardiovascular di
Patients with steroid-dependent Crohn's disease are those who respond to steroid therapy but cannot taper the treatment. Steroid-refractive patients are those who fail to respond to adequate treatment dosages of up to 1 mg per kg of prednisone within
Author: Richard Sadovsky
Date: March 1, 2003
The widespread frequency of serum blood chemistry analyses in medicine requires an appropriate guideline for evaluating abnormal test results. Guidelines have been developed by the Clinical Practice Committee of the American Gastroenterological Association to interpret results and follow patients with abnormal liver chemistry test results.
Because normal values for serum biochemical tests are defined by the mean of the distribution plus or minus two standard deviations among a healthy population, 2.5 percent of healthy persons will have abnormal test elevations. In addition, because a normal value does not exclude the possibility of hepatic disease, test results must be interpreted in the context of the individual patient, and a detailed history, physical examination, and medication review are required. Important factors in this evaluation include risk factors for liver disease, medications associated with liver chemistry abnormalities, comorbid conditions, alcohol consumption, and other evidence of liver disease. This information base may appropriately direct the examination toward establishing specific diagnoses. When no clues exist or a diagnosis cannot be confirmed, an algorithm for evaluation of liver test abnormalities can be useful.
Elevated serum aminotransferase levels indicate the need to test for common hepatic diseases with noninvasive testing. If these results are negative, further testing should be based on the clinical situation. Clinical follow-up and serial serum liver chemistry testing is important. If aminotransferase elevations are persistent or marked, or if there is evidence of liver disease, a more complete diagnostic effort is required, which may include radiologic testing and liver biopsy.
Hyperbilirubinemia can be caused by hepatocellular, cholestatic, or metabolic diseases and requires further evaluation. Initial evaluation should identify whether hyperbilirubinemia is conjugated (direct) or unconjugated (indirect). Mild indirect hyperbilirubinemia in an asymptomatic patient may indicate Gilbert's syndrome, hemolysis, or a medication adverse effect. Conjugated hyperbilirubinemia in the presence of an elevated alkaline phosphatase level warrants evaluation for biliary obstruction with ultrasonography.
An elevated serum alkaline phosphatase level in the presence of normal aminotransferase levels warrants testing of g-glutamyltransferase or 5-nucleotidase testing. If these results are negative, some other etiology should be sought for the elevated serum alkaline phosphatase level outside of the hepatobiliary tract. If these results are positive, further testing is necessary to look for biliary obstruction, medication adverse effects, or primary biliary cirrhosis.
The authors conclude that mild liver abnormalities found in patients who appear to be healthy can be followed up closely if initial testing for common liver disease is negative. Further evaluation is essential in patients who have significant symptoms, chronic or serious liver disease, and marked laboratory abnormalities.
Richard SadovskyClinical Practice Committee.American Gastroenterological Association medical positionstatement: evaluation of liver chemistry tests.Gastroenterology October 2002; 123:1364-6.COPYRIGHT 2003 American Academy of Family PhysiciansCOPYRIGHT 2003 Gale Group